BridgeMD
New treatment option for Femur Shaft Fracture
Official title Assessing Bone Fracture Healing Effect of Almonds
ClinicalTrials.gov ID: NCT07153302
What this study is testing
- What it's testing
- Femur and tibia shaft fractures are common after trauma with a burden of 5% and 20% respectively. Clinicians recommend costly bone strengthening drugs/supplements while treating bone fractures.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 55
You may be able to join if
- Patients of 18 to 55 years of age of any gender.
- Agree and able to voluntary participate.
- Patients with trauma associated femur fracture and tibia shaft fracture arriving at hospital for treatment.
You likely can't join if
- Mentally retarded or patients with severe psychiatric illness.
- Patients are already on bone-strengthening drugs (bisphosphonates, vitamin D, strontium ranelate, teriparatide, etc.).
- Patients who require bone-strengthening drugs for osteoporosis or for any urgent need.
- Severe cardiovascular, hepatic, or renal disease.
- Known allergy or toxicity to Prunus dulcis (almonds) and/or vitamin D supplements.
The study team makes the final eligibility decision.
Where it's taking place
- Karachi, Pakistan
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 55 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Karachi, Pakistan. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.